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Background
Estrogen receptor (ER) has been one of the most intensively 
studied transcription factors, primarily due to its 
importance in breast cancer. Much eff ort has been invested 
in identifying the target genes of ER, mainly by expression 
arrays in breast cancer cell lines and in human tumour 
samples [1,2]. In the past few years, the evolution of 
genomic technologies has permitted mapping of ER-binding 
events in an unbiased manner [3,4]. Th is involves combining 
chromatin immunoprecipitation with micro arrays or high-
throughput sequencing in order to identify ER contact 
points within the genome. Th ese genome-wide experiments 
revealed a number of surprising features about ER biology, 
the most unexpected one being that ER regulates 
transcription mostly from distal enhancers. Th is fi nding 
raised the subsequent question: which of the thousands of 
ER-binding events are the functional ones that regulate 
expression of the few hundred ER target genes? Fullwood 
and colleagues [5] have now established a method for 
addressing this question, allowing researchers to assign ER-
binding events to transcriptional hubs and target genes.
The article
Researchers at the Genome Institute of Singapore have 
developed a technique called ChIA-PET (chromatin 
interaction analysis using paired-end tag sequencing) [5], 
which couples chromosome conformation capture [6], a 
method for identifying interacting chromatin regions, 
with high-throughput sequencing. Th is permits the 
global identifi cation of chromatin loops formed at a 
specifi c time point. Th e authors used a well-established 
system whereby MCF-7 breast cancer cells are cultured 
in hormone-deprived media and subsequently treated 
with estrogen for a short time period, resulting in 
synchronisation of transcriptional events [7]. Using this 
system, the authors could capture the high-confi dence 
chromatin interactions that form during the fi rst wave of 
estrogen-ER-mediated transcription. Th ese interactions 
were extensively validated, supporting their conclusions. 
Th e implications of this investigation are profound. It is 
revealed that chromatin interactions can occur in clusters 
of contact points and that the actual anchor points, in a 
linear two-dimensional represen ta tion, can be found 
separ ated by hundreds of kilobases and in some cases 
megabases. Contrary to previous sugges tions [8], inter-
chromosomal interactions do not appear to be a common 
or experimentally verifi able pheno menon. Th is suggests 
that ER-binding events regulate genes within mostly a 
spatially confi ned environ ment, which in many cases 
involves the folding of multiple regulatory regions into 
one transcriptional hub.
In summary, the authors fi nd 689 ER-associated 
chromatin interaction complexes made up of duplexes 
and more complex interactions. Th ese tend to involve the 
stronger ER-binding events, which are biased toward 
specifi c histone marks and other transcriptional regula-
tors important for ER function, such as FoxA1 [9]. By 
combining the ChIA-PET data with gene expression data, 
they could discover individual transcriptional hubs and 
the target genes localised in the vicinity.
The viewpoint
Until now, researchers have been linking enhancers and 
cis-regulatory elements with the target genes one at a 
time [10,11]. ChIA-PET circumvents this limitation and 
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can identify all active loops at a given time point, allowing 
us to redefi ne the functional ER-binding events. While 
this constitutes the fi rst snapshot of ER-mediated 
chroma tin loops, it is a quantum leap in our under-
standing of transcription dynamics. However, this 
pioneer ing work leads to a series of new questions. Th e 
authors associate the DNA loops that they captured at 
45  minutes of estrogen treatment with a time course 
expression profi le of cells treated with estrogen from 0 to 
48 hours of treatment. A challenging concept that needs 
further testing is whether the chromatin loops (captured 
at 45  minutes) are stable over time or whether they 
change, leading to the formation of new loops at later 
time points to regulate transcription of the ‘late’ target 
genes. Moreover, what is the role of co-operating 
transcription factors in loop formation? Also, since many 
of the ER functional binding events do not directly 
involve promoter regions, one can speculate that some 
DNA loops might circum vent the need for a transcription 
factor to be present at the promoter by concentrating the 
transcription machinery in the three-dimensional hubs.
Furthermore, this technology can be used to explore 
ER chromatin loops and transcriptional hubs in diff erent 
breast cancer cell lines and treatment conditions. Th e 
identifi cation of transcriptionally active binding events in 
the diff erent contexts will illuminate the factors that 
dictate diff erential binding and transcriptional activity. 
However, the major limitations of the ChIA-PET tech-
nology are the complex technical aspects of the proce-
dure, the heavy bioinformatics demand and the require-
ment for high-throughput sequencers. Neverthe less, 
these genomic tools are becoming more readily available, 
and as such, ChIA-PET will prove to be a powerful tool 
for delineating mechanisms of transcription in a spatial 
and temporal manner, applicable to any transcription 
factor of interest.
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